By Benjamin Mueller | NYT | 1 month 2 weeks ago | Science & Environment
A new drug quashes all coronavirus variants. But regulatory hurdles and a lack of funding make it unlikely to reach the U.S. market anytime soon.
RELATED LINKS
CS Monitor - 21 hours 25 minutes ago
NYT - 9 hours 6 minutes ago
NYT - 1 day 3 hours ago
Comments